Search
for

    Sort by

    Research 451–480 of 1000+

    1. Faculty Opinions recommendation of Screening for prostate cancer. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2013
    2. 1452 DETECTION RATE OF CLINICALLY INSIGNIFICANT PROSTATE CANCER INCREASES WITH REPEATING PROSTATE BIOPSIES The Journal of Urology · 2012
    3. Paradigm Shift in the Concept of Hormonal Milieu of Prostate Cancer InTech eBooks · 2011
    4. UP-02.009 Clinical Significance of Intravesical Prostatic Protrusion/Prostate Volume Urology · 2011
    5. S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY European Urology Supplements · 2010
    6. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008
    7. Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática Actas Urológicas Españolas · 2006
    8. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome Cochrane library · 2019 · 54 citations
    9. Medico-Surgical Therapeutic Management of Benign Prostatic Hyperplasia Global Journal of Reproductive Medicine · 2023
    10. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998 · 1054 citations
    11. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992 · 1040 citations
    12. Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia European Urology · 2000 · 184 citations
    13. 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia International Journal of Cancer · 2006 · 57 citations
    14. Finasteride in the treatment of patients with benign prostatic hyperplasia: a review Therapeutics and Clinical Risk Management · 2009 · 33 citations
    15. Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer International Journal of Biological Sciences · 2014 · 23 citations
    16. Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior Journal of Ethnopharmacology · 2014 · 19 citations
    17. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    18. Inhibitory Effects of Serenoa repens on the Kinetic of Pig Prostatic Microsomal 5α-Reductase Activity Endocrine journal · 1998 · 12 citations
    19. In vitro [7-3H]-testosterone metabolism by the rat ventral prostate—Effect of some exogenous compounds Journal of Steroid Biochemistry · 1975 · 12 citations
    20. Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia European urology. Supplement · 2009 · 10 citations
    21. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021 · 8 citations
    22. Treatment Response to Conventional and Novel Therapies in Chronic Prostatitis Current Urology Reports · 2003 · 7 citations
    23. Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study British Journal of Cancer · 2022 · 4 citations
    24. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study Cancer Causes & Control · 2017 · 4 citations
    25. Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 2 citations
    26. Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2 Research Square (Research Square) · 2021 · 1 citations
    27. The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review Consilium Medicum · 2025
    28. Efeitos de diferentes doses do Minoxidil oral, em dois tempos de exposição, no complexo prostático de camundongos Balb/C 2024
    29. Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer Cancers · 2024
    30. Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer The Journal of Urology · 2019